Open-house rebate agreement for Aclidiniumbromid

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jan 03, 2028 · 493 days left·Open·Supplies·Framework

Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Aclidiniumbromid, ATC R03BB05

55/100

Opportunity Score

Needs reviewMedium complexity

SuppliesFrameworkOpen

Why this score?

Opportunity

55 / 100

Complexity

48 / 100

Risk factors

Paper submissions must be sent in duplicate originals, and electronic submissions must use the DTVP communication area...

The notice limits participation to pharmaceutical companies and requires a signed declaration of reliability plus suppo...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Overview

Moderate opportunity

Key Facts

Framework procurement
Supplies contract
1 lot
Duration until Feb 2028
Non-exclusive pharmaceutical rebate agreement for the active substance Aclidiniumbromid (ATC R03BB05).
Open-house model with identical, non-individually negotiable contract terms for all eligible pharmaceutical companies.

Show full summary

This is an open-house pharmaceutical rebate agreement for Aclidiniumbromid (ATC R03BB05) led by AOK Bayern. It is not a competitive award procedure: all interested pharmaceutical companies meeting the stated eligibility conditions may join on identical, non-negotiable terms. The contract period runs from 01.03.2026 to 29.02.2028, with contract entry possible until 03.01.2028. Submission is via DTVP or by signed paper originals; German language is required, and non-German documents must include a German translation.

Risks

Paper submissions must be sent in duplicate originals, and electronic submissions must use the DTVP communication area...

The notice limits participation to pharmaceutical companies and requires a signed declaration of reliability plus suppo...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

Only pharmaceutical companies are eligible as potential contract partners.

Administrative

Submit a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
Submit the completed and signed contract and the completed and signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.

Buyer

Name

AOK Bayern - Die Gesundheitskasse

Location

München, DEU

[email protected]

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-house rebate agreement for Aclidiniumbromid

Single lot open-house supply agreement for pharmaceutical rebate contracts concerning Aclidiniumbromid, ATC R03BB05. The lot is framework-like/open-house in nature, with no selection among bidders and identical contract terms for all eligible pharmaceutical companies. Performance is in Germany, Bavaria (DE212).

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Feb 2026 - Feb 2028

Procurement Details

Publication date: 13 Jan 2026
Languages: German

Reference metadata

Legal basis: 32014L0024

Reference IDs

Tender ID: 25404-2026

Documents (2)

Procurement document 1 Submission portal 1

Similar tenders

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3